Fiera Capital (Europe) Ltd. - Q4 2014 holdings

$136 Million is the total value of Fiera Capital (Europe) Ltd.'s 62 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 32.2% .

 Value Shares↓ Weighting
AVHOQ SellBAIDU INC ADRspon adr rep pfd$24,549,000
+1363.0%
108,039
-11.1%
18.05%
+1390.4%
PODD BuyISHARE MSCI EMRG MKT$21,452,000
+11817.8%
546,201
+11120.2%
15.77%
+12032.3%
EEM NewITAU UNBANCO PRF ADRspon adr pref$19,513,0001,492,345
+100.0%
14.35%
AGN NewAMBEV SA NPV ADRsponsored adr$7,509,0001,150,999
+100.0%
5.52%
BMRN BuyBRADESCO PREF ADRspon adr pref$6,928,000
+14333.3%
515,289
+77503.8%
5.09%
+14454.3%
BAP BuyFOMENTO ECONOMIC ADRcl a$5,901,000
+171.9%
67,073
+373.8%
4.34%
+177.3%
ITUB SellJD.COM ADRspon adr$5,548,000
-73.1%
239,613
-83.8%
4.08%
-72.5%
BBD SellBRASIL FOODS ADRspon adr$4,820,000
-35.1%
205,558
-60.4%
3.54%
-33.8%
SYK BuyTAL EDUCATION ADRspon adr$4,760,000
+5500.0%
169,262
+16066.4%
3.50%
+5637.7%
SellGRUPO TELEVISA ADR$4,522,000
+19.8%
132,540
-52.3%
3.32%
+22.1%
CZZ SellCREDICORP LTD$4,362,000
+814.5%
27,273
-38.7%
3.21%
+832.3%
CELG BuyCIA BRASILEIRA PREFsponsored adr$3,750,000
+2145.5%
101,782
+5696.2%
2.76%
+2197.5%
P103PS BuyPETROBRAS PREF ADRspon adr pref$3,246,000
+3588.6%
426,250
+12639.1%
2.39%
+3688.9%
JNJ BuyLUXOFT HOLDING INC$2,785,000
+287.9%
72,245
+975.4%
2.05%
+295.4%
GRAM BuyGRUPO AVAL ADRspon adr$2,492,000
+8.4%
240,270
+56.6%
1.83%
+10.5%
CBD SellCOPA HOLDINGS SA Asponsored adr$1,980,000
-48.2%
19,072
-78.2%
1.46%
-47.2%
GILD BuyGRANA Y MONTERO ADRspon adr$1,939,000
+353.0%
153,467
+3717.6%
1.43%
+361.5%
TMO BuyULTRAPAR ADRspon adr$1,716,000
+594.7%
89,622
+4336.7%
1.26%
+609.0%
AMPH NewAVIANCA HOLDINGS ADRspon adr rep pfd$1,426,000121,576
+100.0%
1.05%
JD SellJOHNSON & JOHNSON$609,000
-88.8%
5,800
-97.3%
0.45%
-88.6%
PBRA SellPFIZER INC$579,000
-96.9%
18,533
-98.5%
0.43%
-96.9%
UGP SellVALE S.A. ON ADRspon adr$514,000
-72.8%
62,690
-30.1%
0.38%
-72.3%
MDVN BuyMERCK & CO INC$419,000
+84.6%
7,362
+220.9%
0.31%
+87.8%
ABBV  ABBVIE INC$349,000
+12.9%
5,3320.0%0.26%
+15.2%
CPA BuyCOSAN LTD CLASS A$346,000
-84.0%
44,520
+121.1%
0.25%
-83.7%
MRK SellMYLAN INC$289,000
-34.0%
5,115
-30.5%
0.21%
-32.9%
GHDX BuyGILEAD SCIENCES INC$287,000
+635.9%
3,035
+119.9%
0.21%
+653.6%
BRFS SellBRISTOL MYERS SQUIBBsp adr pfd new$262,000
-94.1%
4,427
-97.6%
0.19%
-94.0%
TAL SellTHERMO FISHER$254,000
-95.7%
2,020
-98.8%
0.19%
-95.6%
ABT  ABBOTT LABS$231,000
+8.5%
5,1100.0%0.17%
+10.4%
NSTG BuyNPS PHARMACEUTICALS$229,000
+408.9%
6,389
+56.6%
0.17%
+425.0%
INCY BuyINSULET CORP$224,000
+489.5%
4,868
+533.0%
0.16%
+511.1%
AEGR NewAEGERION PHARMA$202,0009,641
+100.0%
0.15%
BMY SellCELGENE CORPsp adr pfd new$197,000
-13.2%
1,756
-60.3%
0.14%
-11.6%
REGN BuySALIX PHARMACEUTICAL$182,000
+378.9%
1,569
+1394.3%
0.13%
+396.3%
TV SellILLUMINA INC$175,000
-96.3%
948
-99.3%
0.13%
-96.2%
ABEV SellAMGEN INCsponsored adr$156,000
-97.8%
978
-99.9%
0.12%
-97.8%
BIDU SellBECTON DICKINSONspon adr rep a$146,000
-99.4%
1,050
-99.0%
0.11%
-99.4%
PFE SellPHARMACYCLICS INC$143,000
-74.0%
1,168
-93.7%
0.10%
-73.6%
MBT NewMEDIVATION INC$142,0001,420
+100.0%
0.10%
Q SellREGENERON PHARMA$140,000
+159.3%
341
-65.0%
0.10%
+164.1%
IPXL SellINCYTE CORPspon adr units$104,000
+52.9%
1,426
-50.2%
0.08%
+55.1%
MYL BuyNANOSTRING TECH$103,000
-56.0%
7,451
+45.7%
0.08%
-55.0%
SLXP SellSTRYKER CORP$99,000
-47.3%
1,047
-12.5%
0.07%
-46.3%
AMGN BuyAMPHASTAR PHARMA$98,000
+3.2%
8,451
+1152.0%
0.07%
+4.3%
ILMN BuyIMPAX LABORATORIESspon adr units$91,000
-41.7%
2,865
+202.2%
0.07%
-40.7%
BDX SellBIOGEN IDEC INC$80,000
-33.3%
236
-77.5%
0.06%
-32.2%
BIIB BuyBIOMARIN PHARMA$60,000
-23.1%
664
+181.4%
0.04%
-21.4%
PCYC BuyQUINTILES TRANS$58,000
-47.3%
973
+3.8%
0.04%
-45.6%
FMX SellGENOMIC HEALTH INCcl a$44,000
-99.3%
1,380
-97.9%
0.03%
-99.3%
MDCO ExitMEDICINES CO$0-970
-100.0%
-0.02%
BSX ExitBOSTON SCIENTIFIC CORP$0-2,262
-100.0%
-0.02%
CBST ExitCUBIST PHARMACEUTICALS INC$0-612
-100.0%
-0.03%
THRX ExitTHERAVANCE INC$0-4,532
-100.0%
-0.06%
TBPH ExitTHERAVANCE BIOPHARMA INC$0-4,340
-100.0%
-0.07%
ExitALLERGAN INC$0-830
-100.0%
-0.11%
OREX ExitOREXIGEN THERAPEUTICS INC$0-35,200
-100.0%
-0.11%
SNY ExitSANOFIsponsored adr$0-2,700
-100.0%
-0.11%
MDT ExitMEDTRONIC INC$0-2,718
-100.0%
-0.12%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-5,000
-100.0%
-0.32%
PBR ExitPETROLEO BRASILEIRO SA PETROsponsored adr$0-39,657
-100.0%
-0.40%
ExitCREDICORP LTD$0-14,517
-100.0%
-1.60%
VNET Exit21VIANET GROUP INCsponsored adr$0-176,285
-100.0%
-2.29%
VALE ExitVALE S Aadr$0-338,040
-100.0%
-2.68%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-02-06
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
JD.COM ADR16Q1 201718.4%
GENOMIC HEALTH INC16Q1 20179.1%
PFIZER INC16Q1 201713.5%
FOMENTO ECONOMIC ADR16Q1 20175.1%
BRISTOL MYERS SQUIBB16Q1 20174.8%
BECTON DICKINSON15Q1 201721.4%
AMGEN INC14Q1 20179.3%
BRASIL FOODS ADR14Q1 20178.1%
VALE S A14Q1 201713.5%
PHARMACYCLICS INC14Q1 20170.8%

View Fiera Capital (Europe) Ltd.'s complete holdings history.

Latest filings
TypeFiled
13F-NT2024-02-13
13F-NT2023-11-02
13F-NT2023-08-08
13F-NT2023-05-09
13F-NT2023-02-13
13F-NT2022-11-14
13F-NT2022-08-09
13F-NT2022-05-16
13F-NT2022-02-11
13F-NT2021-11-12

View Fiera Capital (Europe) Ltd.'s complete filings history.

Compare quarters

Export Fiera Capital (Europe) Ltd.'s holdings